Monthly Archives: October 2013
Oxford Medical Diagnostics develops and supplies breath analysis technologies for rapid, accurate, and low-cost monitoring of diseases and metabolic functions.
The current focus of OMD’s work is the development of a breath test to indirectly measure blood ketones. This test is designed to assist type 1 diabetics with their condition and its complications, particularly diabetic ketoacidosis, the main cause of mortality in diabetics. It is envisaged that this will provide a completely non-invasive, more user-friendly and accurate test compared with the current standard blood ketone strips, which require blood samples from a painful finger stick.
Developed within Professor Gus Hancock’s research group at the University of Oxford, the Company’s major proprietary technology – Cavity Enhanced Absorption Spectroscopy – allows the measurement of acetone at sub-parts-per-million levels in breath. The technology allows for sensitivity far beyond the current industry standard. There is also significant potential to exploit breath acetone measurements in a separate device as a surrogate marker for blood glucose.
OMD has brought together a highly experienced management team to realise the significant potential of the CEAS technology platform. The Company maintains close links with the University of Oxford and academics around the world.
SafeClickTM is Future Injection Technologies’ (FIT’s) family of novel and proprietary single use
disposable auto-injectors that allows self-administration of viscous biological and standard therapies via regulatory standard pre-filled syringes.
Epicardio key innovation is based on software solutions that enable real-time 3D simulations to execute on common desktop/laptop computers and the iPad. For the first time, medical “learning-by-doing” is accessible on widely available consumer devices, via standard internet connections. Epicardio simulators bridge the training gap between theory and medical practice by enabling trainee doctors to gain direct experience of how disease can cause changes in organ function. The solution is scalable to a wide range of specialist and non-specialist training, e.g. cardiology, orthopaedics, neurology, endoscopies, etc. The innovative features of the Epicardio computer based simulation are being patented and further R&D is focused on developing the technology into a complete patient-specific diagnostic solution for cardiology.
focus is the secure and industrialized Information Management of Omics projects. Enabling science teams to store, create, annotate, track data and pipelines in a web based environment. Using a hybrid cloud approach we can seamlessly complement your existing infrastructure investments. We make your Omics data assets more portable, reproducible and reusable. The benefits are accelerated scientific research and improved effectiveness and efficiency.
BioMimOx is an early stage biotech company investigating a proprietary peptide display platform for selection and affinity maturation of peptide aptamers and antibodies for use in research, diagnostics and biotherapeutics. We are also to investigate proprietary peptide aptamers and library construction as next generation affinity ligand binders.
Introducing the Freescale Freedom Development Platform FRDM-KL25Z
Freescale Freedom Boards distributed by Mouser Electronics – Product Overview
Chilli sensor developed at the University of Oxford is to be manufactured by Singapore spin-out, Bio-X (S) Pte. Ltd. to bring standardisation for heat in the food industry. The mass-produced sensor could see the ubiquitous chilli symbols on food packaging replaced by Scoville units. The sensor measures the levels of capsaicinoids, chemicals in chillies that gives us the characteristic ‘heat’. The most common method of assessing the heat at the moment involves a panel of tasters – which takes time, incurs costs and often yields variable results. The handheld Chilli Tester uses nanotechnology to give an accurate measure in minutes.
The technology is licensed from Isis Innovation, the Technology Transfer Company of Oxford University, by Bio-X Ltd., a Singapore company that already deals with chemical sensors. The CEO of Bio-X (S) Pte. Ltd., Mr. Donald Foo, explained the attraction of chilli sensor technology: “With a Chilli Tester to measure the spiciness and grade products, it will provide a common understanding for heat. Spiciness is subjective and varies from culture to culture. An Asian’s tolerance for spiciness is generally different from a European’s.”